Laplace Interventional, based in Plymouth, MN, is a medical device company specializing in the development of transcatheter tricuspid valve technology. Founded by Ramji Iyer, who serves as CEO, the company aims to improve the lives of patients through innovative medical equipment. Laplace Interventional recently closed a $12.9 million Series B financing round, underscoring its growth and investor confidence. The company's investigational device targets over 500,000 patients in the US and EU diagnosed with tricuspid valve conditions, aiming to enhance both life expectancy and quality of life.